Zobrazeno 1 - 10
of 187
pro vyhledávání: '"James R. Seibold"'
Autor:
Ann Julie Impens, James R. Seibold
Publikováno v:
International Journal of Rheumatology, Vol 2010 (2010)
Sexual dysfunction is common in systemic sclerosis (SSc). Male erectile dysfunction (MED) has been reported in around 80% of subjects and more than half of female patients fulfill criteria for diagnosis as female sexual arousal Disorder (FSAD). While
Externí odkaz:
https://doaj.org/article/2d4c2a0e4ac64096bdddbece6e328e06
Autor:
Eric L, Matteson, Clive, Kelly, Jörg H W, Distler, Anna-Maria, Hoffmann-Vold, James R, Seibold, Shikha, Mittoo, Paul F, Dellaripa, Martin, Aringer, Janet, Pope, Oliver, Distler, Alexandra, James, Rozsa, Schlenker-Herceg, Susanne, Stowasser, Manuel, Quaresma, Kevin R, Flaherty
Publikováno v:
Arthritis & Rheumatology. 74:1039-1047
To analyze the efficacy and safety of nintedanib in patients with fibrosing autoimmune disease-related interstitial lung diseases (ILDs) with a progressive phenotype.The INBUILD trial enrolled patients with a fibrosing ILD other than idiopathic pulmo
Autor:
Ariane L Herrick, Andrea Murray, Graham Dinsdale, Joanne Manning, Chukwuma Chukwu, Marcia Alvarez Fernandez, James R Seibold, Fredrik Tiberg
Publikováno v:
Rheumatology. 62
Background/Aims Prostacyclin analogues, although effective treatment for systemic sclerosis (SSc)-related Raynaud’s phenomenon (RP), have the disadvantage of requiring intravenous or subcutaneous (SC) infusion. Treprostinil subcutaneous depot (CAM2
Autor:
Joshua J Solomon, Vibeke Strand, Chester V. Oddis, Leticia Kawano-Dourado, Tracy J. Doyle, Jeffrey A. Sparks, Kevin K. Brown, Susanna Proudman, Athol U. Wells, Donald P. Tashkin, Dorcas E. Beaton, Dinesh Khanna, Whitney Townsend, Lara J Maxwell, Shaney L Barratt, James R. Seibold, Paul F. Dellaripa, Robert Vassallo, David Roofeh, Eric L. Matteson, Thomas Leonard, Robin Christensen
Publikováno v:
Semin Arthritis Rheum
Roofeh, D, Barratt, S L, Wells, A U, Kawano-Dourado, L, Tashkin, D, Strand, V, Seibold, J, Proudman, S, Brown, K K, Dellaripa, P F, Doyle, T, Leonard, T, Matteson, E L, Oddis, C V, Solomon, J J, Sparks, J A, Vassallo, R, Maxwell, L, Beaton, D, Christensen, R, Townsend, W & Khanna, D 2021, ' Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease : A systematic review using the OMERACT filter 2.1 process ', Seminars in Arthritis and Rheumatism, vol. 51, no. 6, pp. 1331-1341 . https://doi.org/10.1016/j.semarthrit.2021.08.001
Roofeh, D, Barratt, S L, Wells, A U, Kawano-Dourado, L, Tashkin, D, Strand, V, Seibold, J, Proudman, S, Brown, K K, Dellaripa, P F, Doyle, T, Leonard, T, Matteson, E L, Oddis, C V, Solomon, J J, Sparks, J A, Vassallo, R, Maxwell, L, Beaton, D, Christensen, R, Townsend, W & Khanna, D 2021, ' Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease : A systematic review using the OMERACT filter 2.1 process ', Seminars in Arthritis and Rheumatism, vol. 51, no. 6, pp. 1331-1341 . https://doi.org/10.1016/j.semarthrit.2021.08.001
Objective The Outcome Measures in Rheumatology (OMERACT) is a research organization focused on improving health care outcomes for patients with autoimmune and musculoskeletal diseases. The Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
Autor:
Ganesh Raghu, Yannick Allanore, John D Pauling, Marco Matucci-Cerinic, Michael L. Whitfield, Daniel E. Furst, Christopher P. Denton, Panduranga S. Rao, James R. Seibold, Vivek Nagaraja, Dinesh Khanna, Masataka Kuwana, Vallerie V. McLaughlin
Publikováno v:
Arthritis Rheumatol
Systemic sclerosis (SSc) is an autoimmune rheumatic disease with heterogeneous clinical manifestations and a variable course in which the severity of the pathology dictates the disease prognosis and course. Among autoimmune rheumatic diseases, SSc ha
Autor:
David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A Johannson, Yannick Allanore, Eric L Matteson, Leticia Kawano-Dourado, John D Pauling, James R Seibold, Elizabeth R Volkmann, Simon L F Walsh, Chester V Oddis, Eric S White, Shaney L Barratt, Elana J Bernstein, Robyn T Domsic, Paul F Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C Mathai, Vibeke Strand, Tracy J Doyle, Virginia Steen, Donald F Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna
Publikováno v:
Rheumatology
Rheumatology, 2023, 62 (5), pp.1877-1886. ⟨10.1093/rheumatology/keac557⟩
Rheumatology, 2023, 62 (5), pp.1877-1886. ⟨10.1093/rheumatology/keac557⟩
Objectives To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). Methods A conceptual framework for subclinical, clinical and progressive ILD was provided to 83 experts,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755d23ee0c80cf18c0d4d04dde5d7062
https://hdl.handle.net/2434/962120
https://hdl.handle.net/2434/962120
Autor:
Doris Damian, Patricia Fleuranceau-Morel, Stephen Wax, Donald P. Tashkin, Cristina Vazquez-Mateo, Athol U. Wells, Dinesh Khanna, James R. Seibold, Christopher P. Denton
Publikováno v:
The Journal of rheumatology. 48(8)
ObjectiveTo investigate the effects of abituzumab in systemic sclerosis–associated interstitial lung disease (SSc-ILD).MethodsSTRATUS was a phase II, double-blind, parallel-group, multicenter trial (ClinicalTrials.gov: NCT02745145). Adults (≤ 75
Autor:
James R. Seibold, Vanessa Smith, Francesco Del Galdo, Petros P. Sfikakis, Madelon C. Vonk, Maurizio Cutolo
Publikováno v:
Autoimmunity Reviews, 20
Autoimmunity Reviews, 20, 12
AUTOIMMUNITY REVIEWS
Autoimmunity Reviews, 20, 12
AUTOIMMUNITY REVIEWS
Contains fulltext : 244673.pdf (Publisher’s version ) (Open Access) Many therapies have been investigated for systemic sclerosis-associated interstitial lung disease (SSc-ILD), including immunosuppressive therapies, antifibrotic agents, immunomodul
Autor:
JG Coghlan, Harbajan Chadha-Boreham, Oliver Distler, Ulf Müller-Ladner, Madelon C. Vonk, Carina Mihai, Janet E. Pope, Martin Doelberg, Vallerie V. McLaughlin, Dinesh Khanna, Rucsandra Dobrota, Diana Bonderman, Daniel M Rosenberg, Ekkehard Grünig, James R. Seibold, Christopher P. Denton, Milos Antic
Publikováno v:
Annals of the Rheumatic Diseases, 77, 1, pp. 128-132
Annals of the Rheumatic Diseases, 77, 128-132
Annals of the Rheumatic Diseases, 77, 128-132
ObjectivePulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc). In this longitudinal study, we aimed to identify factors associated with an unfavourable outcome in patients with SSc with early PAH (SSc-PAH) from t
Autor:
Stanford L. Peng, Kristan D. Rollins, Robert Spiera, Robert W. Simms, Dinesh Khanna, John Varga, Virginia D. Steen, Maureen D. Mayes, Fredrick M. Wigley, Naomi F. Rothfield, Barri J. Fessler, Bashar Kahaleh, Lorinda Chung, Richard M. Silver, David H. Collier, Elena Schiopu, Robyn T. Domsic, Soumya Chatterjee, Michael Wade, Christopher P. Denton, Murray Baron, Kevin Laliberte, Jerry A. Molitor, Mary Ellen Csuka, Vivien Hsu, Thomas A. Medsger, James R. Seibold, Ariane L. Herrick, Tracy M. Frech, Janet E. Pop
Publikováno v:
Journal of Scleroderma and Related Disorders. 2:42-49
Background Prostacyclins are routinely used to treat vascular features of systemic sclerosis (SSc, scleroderma) but require parenteral infusion or inhalation. This study evaluated the safety and efficacy of oral treprostinil in digital ulcers seconda